The 116th Congress House Committee on Appropriations submitted a report in explanation of bill H.R. 2740, the Omnibus that funds Health and Human Services (HHS) including the National Institute of Health (NIH) and the Centers for Disease Control (CDC), and outlines the final legislative language and designation of funds for vector-borne diseases, including Lyme disease, for fiscal year ending September 30, 2020.

Language in House Report includes: “The agreement urges NIAID, in coordination with CDC, to study the long-term effects on patients suffering from post-treatment Lyme disease syndrome, or 'chronic Lyme disease'. Specifically, the agreement urges NIAID to evaluate the effectiveness of laboratory tests associated with the detection of Borrelia burgdorferi to diagnose the disease early, which can improve the treatment of patients suffering from Lyme disease.

The agreement is aware of promising vaccine innovations to combat Borrelia and